Cavinato Lara, Sollini Martina, Ragni Alessandra, Bartoli Francesco, Zanca Roberta, Pasqualetti Francesco, Marciano Andrea, Ieva Francesca, Erba Paola Anna
MOX-Modeling and Scientific Computing, Department of Mathematics, Politecnico di Milano, p.zza Leonardo da Vinci 32, 20133 Milan, Italy.
Department of Biomedical Sciences, Humanitas University, Via R. Levi Montalcini 4, 20090 Pieve Emanuele, Italy.
Cancers (Basel). 2023 Jan 29;15(3):823. doi: 10.3390/cancers15030823.
Advanced image analysis, including radiomics, has recently acquired recognition as a source of biomarkers, although there are some technical and methodological challenges to face for its application in the clinic. Among others, proper phenotyping of metastatic or systemic disease where multiple lesions coexist is an issue, since each lesion contributes to characterization of the disease. Therefore, the radiomic profile of each lesion should be modeled into a more complex architecture able to reproduce each "unit" (lesion) as a part of the "entire" (patient). This work aimed to characterize intra-tumor heterogeneity underpinning metastatic prostate cancer using an exhaustive innovative approach which consist of a i) feature transformation method to build an agnostic (i.e., irrespective of pre-existence knowledge, experience, and expertise) radiomic profile of lesions extracted from [F]FMCH PET/CT, ii) qualitative assessment of intra-tumor heterogeneity of patients, iii) quantitative representation of the intra-tumor heterogeneity of patients in terms of the relationship between their lesions' profiles, to be associated with prognostic factors. We confirmed that metastatic prostate cancer patients encompassed lesions with different radiomic profiles that exhibited intra-tumor radiomic heterogeneity and that the presence of many radiomic profiles within the same patient impacted the outcome.
包括放射组学在内的先进图像分析最近已被认可为生物标志物的来源,尽管其在临床应用中面临一些技术和方法上的挑战。其中,在存在多个病灶的转移性或全身性疾病的正确表型分析是一个问题,因为每个病灶都对疾病的特征有贡献。因此,每个病灶的放射组学特征应被建模为一个更复杂的结构,能够将每个“单元”(病灶)作为“整体”(患者)的一部分进行再现。这项工作旨在使用一种详尽的创新方法来表征转移性前列腺癌的肿瘤内异质性,该方法包括:i)一种特征转换方法,用于构建从[F]FMCH PET/CT中提取的病灶的不可知(即不考虑先验知识、经验和专业知识)放射组学特征;ii)对患者肿瘤内异质性的定性评估;iii)根据患者病灶特征之间的关系对患者肿瘤内异质性进行定量表示,以便与预后因素相关联。我们证实,转移性前列腺癌患者的病灶具有不同的放射组学特征,表现出肿瘤内放射组学异质性,并且同一患者体内存在多种放射组学特征会影响预后。